When it comes to growth investing, there are some key challenges that investors face. Jeremy Schwartz and Kara Marciscano explain how our just launched U.S. Growth & Momentum Fund (WGRO) seeks to solve for these challenges.
At WisdomTree, we believe that one of the biggest megatrends over the coming decades will relate to biotechnology. With an expanding global population and greater attention being paid to sustainability, novel approaches to agriculture may become an important focus in the long run. Christopher Gannatti discusses this growing megatrend.
Read the article
The new rate hike cycle has provided lower valuation entry points for investors seeking exposure to megatrends. Kara Marciscano gives an overview of a few of our megatrend Funds and recaps their recent performances.
Read the article
With today's volatile market, equity investors are now more interested in cash flows, earnings and dividends rather than exciting stories of massive future potential. Christopher Gannatti looks at the BioRevolution, which has been 'repricing' innovation in early 2022.
Read the article
Our Global Head of Research, Christopher Gannatti, explains how Artificial Intelligence contributes to areas of the BioRevolution.
Read the article
Since the November Fed meeting, there have been expectations that the Fed will begin raising interest rates in 2022. Kara Marciscano checks in on a few of our megatrend Funds and discusses how they have been impacted by recent Fed guidance.
Read the article
Thematic or megatrend strategies typically focus on the coming wave of ‘big ideas’ for equities. But what do some of these big ideas really look like in their implementation? Christopher Gannatti discusses.
